Search - tctmd.com

Displaying 201 - 220 of 258

Sort: Relevancy | Date

News Daily News

AHA Advises Physicians to Monitor Medications That Might Cause or Worsen Heart Failure

Michael H. Wilson

July 12, 2016

News Daily News

New A-fib Performance and Quality Measures Emphasize Shared Decision-Making, Inpatient and Outpatient Care

Michael O'Riordan

June 29, 2016

News Daily News

With Greater Uptake, ARNIs Could Potentially Save the Lives of Nearly 30,000 Patients Each Year

Michael H. Wilson

June 28, 2016

News Daily News

Pharmacists Can Take an Active Role in Lowering CV Risk Factors, Likelihood of Events

Michael H. Wilson

June 21, 2016

Presentation TVT 2016

Tricuspid Regurgitation: Etiology, Pathophysiology, and Scope of the Problem

Presenter: Adam B. Greenbaum

June 17, 2016

News Conference News EuroPCR 2016

Of Hands and Hearts: Upper-Extremity Dysfunction Common Early After Transradial PCI

Michael O'Riordan

May 18, 2016

News Daily News

When Problems Arise With Prosthetic Heart Valves, Multimodality Imaging Is Needed, Say European Guidelines

Todd Neale

May 06, 2016

News Daily News

Another CV Outcomes Trial Testing Weight-Loss Drug Contrave Terminated Early

Michael O'Riordan

April 14, 2016

News Daily News

Most Patients Undergoing Diagnostic Angiography Before Noncardiac Surgery Are Asymptomatic

Michael O'Riordan

March 31, 2016

News Daily News

FDA Tackles Regulatory, Scientific Issues With Point-of-Care Coagulation Monitoring Devices

Todd Neale

March 24, 2016

News Daily News

A Ray of Sunshine: CMS Experts Give an Update on 2 Years of Public Disclosure

Caitlin E. Cox

March 09, 2016

News Daily News

New Roles for Anticoagulation Clinics in an Era of Non-Warfarin Options

Todd Neale

March 01, 2016

News Daily News

Shock’s Added Risk in Acute MI Restricted to the First Few Months After Discharge

Caitlin E. Cox

February 16, 2016

Presentation Aortovascular 2015

Peripheral Artery Disease: A Primer on Scope, Identification and Testing

Presenter: Timothy Crimmins

September 18, 2015

News Daily News

A-fib, Whether Preexisting or New-Onset, Tied to Poor Outcomes in TAVR

Yael L. Maxwell

August 30, 2015

News Industry News

New Cost Effectiveness Model Underlines Scope of Polypill Strategy to Prevent Recurring Cardiovascular Events and for More Efficient Use of Health Budgets

June 19, 2015

News Industry News

DalCor Pharma licenses a late-stage investigational cardiovascular drug following major discovery by Montreal Heart Institute (MHI) scientists

June 08, 2015

News Opinion Editor's Corner

Editor's Corner: Beyond the Cath Lab

Caitlin E. Cox

June 01, 2015

News Featured Fellow

Triston Smith, MD

Yael L. Maxwell

April 23, 2015

News Daily News

ASSURE Registry: Angiographic, Clinical Outcomes of BRS Similar to DES at 1 Year

L.A. McKeown

December 21, 2014

Advertisement

AHA Advises Physicians to Monitor Medications That Might Cause or Worsen Heart Failure

New A-fib Performance and Quality Measures Emphasize Shared Decision-Making, Inpatient and Outpatient Care

With Greater Uptake, ARNIs Could Potentially Save the Lives of Nearly 30,000 Patients Each Year

Pharmacists Can Take an Active Role in Lowering CV Risk Factors, Likelihood of Events

Tricuspid Regurgitation: Etiology, Pathophysiology, and Scope of the Problem

Of Hands and Hearts: Upper-Extremity Dysfunction Common Early After Transradial PCI

When Problems Arise With Prosthetic Heart Valves, Multimodality Imaging Is Needed, Say European Guidelines

Another CV Outcomes Trial Testing Weight-Loss Drug Contrave Terminated Early

Most Patients Undergoing Diagnostic Angiography Before Noncardiac Surgery Are Asymptomatic

FDA Tackles Regulatory, Scientific Issues With Point-of-Care Coagulation Monitoring Devices

A Ray of Sunshine: CMS Experts Give an Update on 2 Years of Public Disclosure

New Roles for Anticoagulation Clinics in an Era of Non-Warfarin Options

Shock’s Added Risk in Acute MI Restricted to the First Few Months After Discharge

Peripheral Artery Disease: A Primer on Scope, Identification and Testing

A-fib, Whether Preexisting or New-Onset, Tied to Poor Outcomes in TAVR

New Cost Effectiveness Model Underlines Scope of Polypill Strategy to Prevent Recurring Cardiovascular Events and for More Efficient Use of Health Budgets

DalCor Pharma licenses a late-stage investigational cardiovascular drug following major discovery by Montreal Heart Institute (MHI) scientists

Editor's Corner: Beyond the Cath Lab

Triston Smith, MD

ASSURE Registry: Angiographic, Clinical Outcomes of BRS Similar to DES at 1 Year

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content